by creavo | Sep 2, 2019 | News, Press Release
August 2019: UK medical device company Creavo Medical Technologies has appointed its Operations Director Andrew Mullen to its Board of Directors, a role which will see him lead on research and development (R&D) and regulatory affairs. Andrew has held the...
by creavo | May 22, 2019 | News
We are pleased to share that our technology has been featured in The Future of Healthcare, special report in The Times. The piece features Steve Parker, our Chief Executive, sharing the innovative potential of our technology to address a significant unmet healthcare...
by creavo | May 22, 2019 | News
Creavo is honored to have its portable magnetocardiography (MCG) *device, Corsens®, displayed as part of the Institute of Engineering and Technology (IET) ‘100 objects that have changed the world’ exhibition in London. Creavo was recognised at the IET awards 2018,...
by creavo | Apr 15, 2019 | News
Creavo celebrates 5-year anniversary By Steve Parker, Chief Executive Officer This week marks five years since Creavo was formed – and another milestone as we celebrate Creavo entering an exciting and pivotal phase in its journey. We are now in the final stages of...
by creavo | Apr 1, 2019 | News
Coventry medtech company expands into new office as it prepares for further growth. The move marks five years since Creavo was formed. Coventry-based medtech company Creavo Medical Technologies (Creavo), has moved to a new site in the city to enable it to grow...
by creavo | Feb 27, 2019 | News
Portable MCG technology could transform the treatment of heart disease across the US Frank Peacock, MD, FACEP, FACC Professor, Associate Chair, and Research Director at Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine. American Heart Month...
